OXANDROLONE Drug Patent Profile
✉ Email this page to a colleague
When do Oxandrolone patents expire, and when can generic versions of Oxandrolone launch?
Oxandrolone is a drug marketed by Par Pharm, Roxane, Sandoz, and Upsher Smith Labs. and is included in five NDAs.
The generic ingredient in OXANDROLONE is oxandrolone. There are ten drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the oxandrolone profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OXANDROLONE?
- What are the global sales for OXANDROLONE?
- What is Average Wholesale Price for OXANDROLONE?
Summary for OXANDROLONE
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 5 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 39 |
| Clinical Trials: | 23 |
| Patent Applications: | 2,699 |
| Drug Prices: | Drug price information for OXANDROLONE |
| DailyMed Link: | OXANDROLONE at DailyMed |
Recent Clinical Trials for OXANDROLONE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| George F. Hatch | Phase 4 |
| University Hospital, Clermont-Ferrand | Phase 2 |
| United States Department of Defense | Phase 3 |
Medical Subject Heading (MeSH) Categories for OXANDROLONE
Anatomical Therapeutic Chemical (ATC) Classes for OXANDROLONE
Paragraph IV (Patent) Challenges for OXANDROLONE
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| OXANDRIN | Tablets | oxandrolone | 2.5 mg and 10 mg | 013718 | 1 | 2006-06-19 |
US Patents and Regulatory Information for OXANDROLONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Par Pharm | OXANDROLONE | oxandrolone | TABLET;ORAL | 077827-001 | Jun 22, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Upsher Smith Labs | OXANDROLONE | oxandrolone | TABLET;ORAL | 076761-001 | Dec 1, 2006 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Roxane | OXANDROLONE | oxandrolone | TABLET;ORAL | 077249-002 | Jul 10, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Upsher Smith Labs | OXANDROLONE | oxandrolone | TABLET;ORAL | 078033-001 | Mar 22, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
